Image from Google Jackets

Research guidelines for evaluating the safety and efficacy of herbal medicines.

Contributor(s): World Health Organization. Regional Office for the Western PacificMaterial type: TextTextSeries: WHO regional office publications. Western Pacific series ; ; no. 8.Publication details: Manila : WHO Regional Office for the Western Pacific, 1993. Description: 86 pISBN: 9290611103Subject(s): Medicine, Herbal | Evaluation studies | Plants, Medicinal | Research | Traditional MedicineNLM classification: WB 925Online resources: Click here to access online Abstract: Sets out detailed guidelines for conducting scientific research on the safety and efficacy of herbal medicines. The guidelines, which reflect the consensus reached by 17 experts in pharmacology, biochemistry, and traditional medicine, respond to the need to assure the safety of widely-used herbal medicines while also facilitating the search for new pharmaceutical products. Specific research criteria are covered together with general principles of investigation, including ethical concerns. The book has three parts. The first discusses the special properties of herbal medicines that need to be considered when designing research protocols, with attention given to the distinctive legal, ethical, and regulatory requirements surrounding research on these substances. The second part provides detailed guidance on the objectives of research, the contents of a research protocol, and the methods of investigation for non-clinical studies and for Phase I to Phase IV clinical trials. The responsibilities of investigators, sponsors, and ethics review boards are also discussed in detail. The third part, which forms the core of the book, presents three sets of research guidelines: for quality specifications of plant materials and preparations, for pharmacodynamic and general pharmacological studies of herbal medicines, and for toxicity investigation of herbal medicines. Topics covered range from the information required to establish the identity and quality of plant materials or preparations, through the selection of appropriate test systems for pharmacodynamic studies, to detailed advice on the many different tests, examinations, observations, and experimental procedures required, in experimental animals and controls, to establish the safety of herbal medicines. The guidelines are intended to facilitate the work of research scientists and clinicians while also furnishing some reference points for the governmental, industrial, and non-profit organizations providing financial support. The guidelines should also prove useful to the regulatory authorities who control the sale of these products and the governmental and medical agencies who supervise their use in the health care systems of Western Pacific countries.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Books Books WHO HQ
READING-RM
WB 925 93RE (Browse shelf(Opens below)) 1 Available 00043177
Books Books WHO HQ
ONLINE-IRIS
WB 925 93RE (Browse shelf(Opens below)) 3 Available O9290611103

Sets out detailed guidelines for conducting scientific research on the safety and efficacy of herbal medicines. The guidelines, which reflect the consensus reached by 17 experts in pharmacology, biochemistry, and traditional medicine, respond to the need to assure the safety of widely-used herbal medicines while also facilitating the search for new pharmaceutical products. Specific research criteria are covered together with general principles of investigation, including ethical concerns. The book has three parts. The first discusses the special properties of herbal medicines that need to be considered when designing research protocols, with attention given to the distinctive legal, ethical, and regulatory requirements surrounding research on these substances. The second part provides detailed guidance on the objectives of research, the contents of a research protocol, and the methods of investigation for non-clinical studies and for Phase I to Phase IV clinical trials. The responsibilities of investigators, sponsors, and ethics review boards are also discussed in detail. The third part, which forms the core of the book, presents three sets of research guidelines: for quality specifications of plant materials and preparations, for pharmacodynamic and general pharmacological studies of herbal medicines, and for toxicity investigation of herbal medicines. Topics covered range from the information required to establish the identity and quality of plant materials or preparations, through the selection of appropriate test systems for pharmacodynamic studies, to detailed advice on the many different tests, examinations, observations, and experimental procedures required, in experimental animals and controls, to establish the safety of herbal medicines. The guidelines are intended to facilitate the work of research scientists and clinicians while also furnishing some reference points for the governmental, industrial, and non-profit organizations providing financial support. The guidelines should also prove useful to the regulatory authorities who control the sale of these products and the governmental and medical agencies who supervise their use in the health care systems of Western Pacific countries.

DC.WPRO

eng.

kor.

WHODOC

WHO monograph

4

There are no comments on this title.

to post a comment.
Implemented & Customized by: OpenLX

Powered by Koha